Report Categories
View AllRecent Articles
View All
How Odysightai ODYS stacks up against analyst expectations 044 20260506
REGCO Regency posts 905 percent Q1 2026 EPS beat as stock edges slightly lower in daily trading
Devon Energy DVN Brokerage Bullish Consensus Aligns With Earnings Momentum Signaling NearTerm Investment Merit
XBIO Xenetic Biosciences reports 31 percent narrower Q2 2025 loss than analyst estimates with shares dipping marginally following the earnings release